48 results on '"Rosenblat, Joshua D"'
Search Results
2. The association between ketamine and esketamine with alcohol and substance misuse: Reports to the Food and Drug Administration adverse event reporting system (FAERS)
3. Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis
4. Effects of anhedonia on health-related quality of life and functional outcomes in major depressive disorder: A systematic review and meta-analysis
5. Association between cognitive functioning, suicidal ideation and suicide attempts in major depressive disorder, bipolar disorder, schizophrenia and related disorders: A systematic review and meta-analysis
6. A replication study using the World Health Organization pharmacovigilance database (VigiBase®) to evaluate whether an association between ketamine and esketamine and alcohol and substance misuse exists
7. Preclinical and clinical efficacy of kappa opioid receptor antagonists for depression: A systematic review
8. Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review
9. A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review
10. The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data
11. Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder
12. Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis
13. Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine Treatment
14. A Systematic review of the validity of screening depression through Facebook, Twitter, Instagram, and Snapchat
15. A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions
16. Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorder
17. Effects of infliximab on brain neurochemistry of adults with bipolar depression
18. The Meaningful Change Threshold as Measured by the 16-Item Quick Inventory of Depressive Symptomatology in Adults with Treatment-Resistant Major Depressive and Bipolar Disorder Receiving Intravenous Ketamine
19. Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence
20. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis
21. The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence
22. The utility of smartphone-based, ecological momentary assessment for depressive symptoms
23. The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data
24. Corrigendum to “Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in major depressive disorder” [J. Affect. Disord.. 238, 2018, pages 228–232]
25. Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression
26. The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysis
27. Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review
28. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive Disorder
29. Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials
30. Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review
31. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder
32. Medical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems
33. Biomarkers of ketamine's antidepressant effect: An umbrella review
34. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications
35. Association between depressive symptoms and bone density in elderly patients with non-dialysis dependent chronic kidney disease
36. The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic review
37. The effect of adjunctive infliximab treatment on future cardiovascular disease risk in patients with bipolar disorder
38. Active mechanisms of ketamine-assisted psychotherapy: A systematic review
39. Corrigendum to “Olanzapine and samidorphan combination treatment: A systematic review”. Journal of Affective Disorders. Volume 301, 15 March 2022, Pages 99-106
40. Immune response to vaccination in adults with mental disorders: A systematic review
41. Olanzapine and samidorphan combination treatment: A systematic review
42. Comparing mortality from covid-19 to mortality due to overdose: A micromort analysis
43. Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review
44. Repetitive transcranial magnetic stimulation for cognitive function in adults with bipolar disorder: A pilot study
45. Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?
46. Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries
47. Corrigendum to “Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review.” J Affect Disord. 241 (2018) 519-532
48. The long-term effect of bariatric surgery on depression and anxiety
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.